Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy-Reference-Cited by-同舟云学术

Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy

Published:2016-09-23 Issue:1 Volume:160 Page:101-109
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kono Miho,Fujii Takeo,Lyons Genevieve Ray,Huo Lei,Bassett Roland,Gong Yun,Karuturi Meghan Sri,Tripathy Debu,Ueno Naoto T.

Funder

Morgan Welch Inflammatory Breast Cancer Research Program

a grant from the State of Texas Rare and Aggressive Breast Cancer Research Program

an award from the Japan Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3986-6.pdf

Reference42 articles.

1. Kennedy BJ (1958) Fluoxymesterone therapy in advanced breast cancer. N Engl J Med 259:673–675

2. Stoll BA (1959) Fluoxymesterone (halotestin) in advanced breast carcinoma. Med J Aust 46:70–74

3. Beckett VL, Brennan MJ (1959) Treatment of advanced breast cancer with fluoxymesterone (halotestin). Surg Gynecol Obstet 109:235–239

4. Kennedy BJ (1957) Fluoxymesterone in the treatment of advanced breast cancer. Cancer 10:813–818

5. Segaloff A, Bowers CY, Rongone EL et al (1958) Hormonal therapy in cancer of the breast. XIII. The effect of 9 alpha-fluoro-17 alpha-methyl-delta 4-androsten3-one-11 beta-17 beta-diol (fluoxymetherone) therapy on clinical course and hormonal excretion. Cancer 11:1187–1189

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating the Activity of Androgen Receptor for Treating Breast Cancer;International Journal of Molecular Sciences;2022-12-05

2. Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer;Technology in Cancer Research & Treatment;2022-01

3. Is it time to consider the Androgen receptor as a therapeutic target in breast cancer?;Anti-Cancer Agents in Medicinal Chemistry;2021-12-01

4. Androgen Receptor in Breast Cancer: From Bench to Bedside;Frontiers in Endocrinology;2020-09-02

5. Androgen receptor in breast cancer: A wolf in sheep’s clothing? A lesson from prostate cancer.;Seminars in Cancer Biology;2020-02